Explore our enterprise-grade active pharmaceutical ingredients, synthesized under stringent cGMP conditions, offering validated purity metrics (>99.5%) via HPLC analysis for global pharmaceutical manufacturing and biotech R&D applications.
The international pharmaceutical market is undergoing a seismic paradigm shift. The demand for high-purity raw steroid powders, complex peptide active pharmaceutical ingredients (APIs), and specialty chemical intermediates is expanding at an unprecedented Compound Annual Growth Rate (CAGR). Modern global regulatory frameworks enforced by the US FDA, EMA, and NMPA necessitate rigorous quality controls, stringent impurity profiling, and robust chemical synthesis pathways.
As global exporters and primary synthesis manufacturers, pharmaceutical clients no longer look merely for material suppliers—they demand strategic partners capable of offering Information Gain through validated analytical data, drug master file (DMF) documentation, and resilient supply chain logistics. Gentolex operates at the forefront of this industrial transformation, bridging technical excellence with absolute compliance.
Achieving superior therapeutic efficacy in steroid derivatives and peptide APIs requires precise stereospecific synthesis, elimination of genotoxic impurities, and zero tolerance for residual organic solvents. Gentolex’s chemical architecture leverages solid-phase peptide synthesis (SPPS), liquid-phase condensation, and advanced continuous-flow microreactors to yield compounds of unmatched structural integrity.
Utilizing state-of-the-art catalytic asymmetric synthesis to control chiral centers with absolute precision, preventing unwanted enantiomers and ensuring optimal biological receptor affinity in target therapeutic molecules.
Every production batch undergoes multi-tiered analytical validation: High-Performance Liquid Chromatography (HPLC) for purity assays, Mass Spectrometry (LC-MS) for mass verification, and Nuclear Magnetic Resonance (NMR) for structural confirmation.
Sterile lyophilization and ultrafiltration processes ensure bioburden and bacterial endotoxin levels remain far below USP/EP standards (<0.05 EU/mg), suitable for parenterally administered finished dosage forms (FDF).
Fourier-Transform Infrared (FTIR) testing of all starting reagents and precursors prior to reactor charging.
Real-time reaction monitoring using inline UV spectroscopy and automated thermal regulation systems.
Multi-stage reverse-phase preparative HPLC purification columns ensuring single-impurity isolation <0.1%.
ICH-compliant accelerated stability testing, thermal stress analysis, and full COA issuance per batch.
Gentolex’s goal is to create opportunities connecting the world with better services and guaranteed products. Up to date, Gentolex Group has been serving customers from more than 10 countries, specially, representatives are established in Mexico and South Africa.
Our main services focus on supplying peptide APIs and Custom Peptides, Finished Dosage Form (FDF) license out, Technical Support & Consultation, Product Line and Lab Setup, Sourcing & Supply Chain Solutions.
For clients who prefer to avoid the complexity of dealing with multiple points of contact, we provide extra customized procurement services with the most superior and comprehensive supply chain sources available globally.
Navigating international regulatory frameworks requires meticulous attention to export/import compliance, customs clearing protocols, and temperature-controlled logistics. Raw steroid powders, therapeutic peptides, and sensitive biological intermediates demand strict storage conditions to prevent degradation.
We supply comprehensive regulatory packages including DMF (Drug Master Files), Certificate of Analysis (COA), Method of Analysis (MOA), Stability Data, Nitrosamine Risk Assessment, and BSE/TSE statements to accelerate customer registration processes worldwide.
Temperature-sensitive peptide APIs and raw powders are packaged in specialized insulated containers using real-time IoT temperature logging devices, ensuring unbroken 2°C to 8°C or -20°C conditions from factory floor to global destination port.
With dedicated regional offices in Mexico, South Africa, and established logistics networks across North America, Europe, and Asia-Pacific, we guarantee smooth customs processing without costly supply chain delays.
Stay informed with the latest scientific breakthroughs, novel peptide synthesis strategies, and technological milestone updates directly from our global research facilities.
Introduction to Selank Acetate API: Selank Acetate API is a synthetic heptapeptide active pharmaceutical ingredient (API) composed of the amino acid sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro (TKPRPGP). Developed through neuropharmacological research, Selank represents a breakthrough in targeted peptide therapeutics...
View Details
Trusted Thymosin Beta-4 API Manufacturer and Global Peptide Supplier: As a professional Thymosin Beta-4 API manufacturer, we provide high-grade Tβ4 peptide API solutions for biotechnology companies, scientific organizations, and international clinical formulation partners...
View Details
Introduction: BPC-157 API is a synthetic pentadecapeptide that has gained increasing attention in peptide research due to its potential biological activities related to tissue repair, gastrointestinal protection, and cellular regeneration. Manufactured under strict cGMP protocols...
View Details
With continuous developments in neuroscience and life science research, neuroactive peptides have become an essential locus of chemical synthesis. Semax, derived from an ACTH fragment, is synthesized with exact sequence control and minimal isomer formation...
View Details
SS-31 API, also known as Elamipretide, MTP-131, Bendavia, is a synthetic mitochondria-targeting tetrapeptide designed to bind cardiolipin in the inner mitochondrial membrane. By stabilizing bioenergetics, SS-31 represents a key clinical API candidate...
View DetailsThe future of pharmaceutical material chemical synthesis lies at the intersection of artificial intelligence, green chemistry, and continuous micro-reaction technology. Gentolex’s 5-year technical vision prioritizes decarbonized production, real-time quantum chemical yield modeling, and automated high-throughput solid-phase peptide synthesis.
Integrating machine learning algorithms to predict side-reaction pathways during peptide coupling and steroid ring functionalization, cutting reaction optimization timelines from months to days while elevating overall yield metrics beyond 98%.
Transitioning from toxic organic solvents to aqueous biocatalytic reactions. Utilizing engineered enzymes for selective hydroxylation and stereo-specific transformations reduces carbon footprints by 45% while eliminating harmful chemical residues.
Replacing traditional batch reactors with microfluidic continuous-flow systems for fast, highly exothermic reactions. This approach guarantees batch-to-batch consistency, tighter heat control, and enhanced operational safety parameters.
Discover our comprehensive portfolio of fine chemicals, peptide APIs, and pharmaceutical raw materials supported by complete regulatory dossiers and global freight options.
Addressing key technical, regulatory, and supply chain inquiries for global pharmaceutical buyers, contract research organizations (CROs), and industrial formulators.
